Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment. [electronic resource]
Producer: 20021118Description: 916-9 p. digitalISSN:- 1073-449X
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Alleles
- Antitubercular Agents -- adverse effects
- Chemical and Drug Induced Liver Injury -- epidemiology
- Female
- Follow-Up Studies
- Genetic Predisposition to Disease
- HLA-DQ Antigens -- genetics
- HLA-DR Antigens -- genetics
- Haplotypes
- Humans
- Immunogenetics
- India -- epidemiology
- Male
- Middle Aged
- Multivariate Analysis
- Risk Factors
- Serum Albumin -- metabolism
- Tuberculosis, Pulmonary -- complications
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.